查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1804621

核子医学软体市场按产品类型、工作流程、整合、功能、部署模式、应用程式和最终用户划分—2025-2030 年全球预测

Nuclear Medicine Software Market by Product Type, Workflow, Integration, Functionality, Deployment Mode, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

核医软体市场预计 2024 年将达到 9.1215 亿美元，2025 年将达到 9.9753 亿美元，2030 年将达到 15.748 亿美元，复合年增长率为 9.52%。

主要市场统计数据
基准年2024年 9.1215亿美元
预计2025年 9.9753亿美元
预测年份 2030 15.748亿美元
复合年增长率（%） 9.52%

推动核医软体创新，以提高诊断准确性、简化工作流程并改善患者预后。

在核子医学软体的推动下，影像和治疗计划领域正在经历重大变革。随着医疗服务提供者追求更高的诊断准确性和个人化治疗通讯协定，软体解决方案已远远超越了简单的影像视觉化。现代核子医学平台如今整合了复杂的演算法和即时分析功能，以增强病灶检测、量化放射性示踪剂的摄取，并支援复杂的治疗计画工作流程。利用机器学习模型，临床团队可以辨识多模态资料中以往无法察觉的细微模式，最终改善病患的治疗效果。

揭示核子医学软体架构、资料工作流程、分析能力和临床决策支援范式的革命性转变

核子医学软体生态系统正在经历一系列变革性发展，从核心架构到终端用户应用。人工智慧和深度学习技术正从先驱性研究转向主流诊断模组，实现病变自动分割、异常检测和预测分析。这些工具不再是孤立的实验，而是越来越多地被纳入临床决策支援系统，从而增强医生的专业知识并减少操作者之间的差异。

评估2025年美国关税政策对核医软体供应链、成本和创新途径的连锁反应

美国2025年关税政策的不断演变，为支持核医软体开发和部署的供应链带来了复杂的动态。许多国际采购的专用硬体组件和云端基础设施服务都面临进口关税上调的风险。这直接导致软体供应商面临营运成本上升的问题，并被迫重新评估其全球筹资策略。为了降低成本上升的影响，一些供应商正在透过多元化製造地或投资国内组装伙伴关係来应对。

揭示核子医学软体中产品类型、工作流程、整合、功能、部署模型、应用程式和最终用户需求的关键细分洞察

細項分析揭示了核医软体产品和使用者需求在多个维度上蕴含的细微商机。在产品系列中，影像处理软体凭藉其直观的用户介面和先进的重建演算法备受关注；临床决策支援模组利用预测分析来指导治疗方案；数据管理平台专注于安全储存、搜寻和合规性追踪；放射治疗计划解决方案则将剂量计算与患者特定的解剖模型相结合。每个产品类型应对不同的临床挑战，并塑造供应商蓝图和投资重点。

探索影响全球核子医学软体采用趋势、成长动力、法规环境和基础设施发展的多样化区域动态

区域分析显示，美洲、欧洲、中东和非洲以及亚太地区呈现不同的采用模式和战略重点。在美洲，先进的医疗基础设施，加上诊断影像和标靶治疗的支持性报销政策，正在推动云端原生和人工智慧平台的广泛采用。领先的医疗机构正在大力投资能够与现有 PACS 网路和电子健康记录无缝整合的软体，优先考虑能够提高业务效率和患者吞吐量的解决方案。

介绍核医软体市场的主要创新者和新兴参与者，揭示策略伙伴关係、技术突破和竞争定位

领先的技术供应商透过策略合作、收购和内部创新持续完善其核心平台。主流技术供应商正在扩展其产品组合，纳入高级分析模组，利用专有机器学习框架加速病变量化和疗效评估。同时，一些灵活的新兴企业正在开拓利基市场，专注于儿科影像和感染疾病监测等专业临床应用，并与学术医疗中心合作，在现实环境中检验其演算法。

为产业领导者提供可行的建议，以利用技术进步、优化投资并加强其在核医软体领域的策略地位

产业领导者应优先采用人工智慧主导的分析技术，以提高准确性和业务效率。将检验的模型整合到现有工作流程中，可以帮助组织缩短解读时间，并支援更早的临床介入。同时，采用模组化元件的云端原生架构可确保扩充性和灵活性，从而能够在中心化医院和分散式门诊影像中心快速部署。

概述一种严谨的调查方法，利用初步访谈、二次资料检验和强大的分析技术来确保见解的准确性和可靠性

调查团队采用多阶段调查方法，确保获得全面且可靠的见解。初始阶段包括广泛的案头研究，利用同行评审期刊、监管出版物和特定主题的白皮书，明确市场边界并识别关键相关人员。此阶段为有针对性的初步研究活动奠定了基础，包括与临床负责人、软体开发人员、放射科主任和合规专家进行结构化访谈。

关于技术趋势、市场驱动因素、区域差异以及指导核医软体生态系统未来的策略要点的主要发现的综合

这项研究表明，核医软体正处于人工智慧、云端运算和精准医疗整合的关键时刻。机器学习演算法的技术突破正在提高诊断准确性，使临床医生能够做出更快、更明智的决策。同时，向可互通的云端原生解决方案的转变正在重塑资料工作流程，并实现跨设施和跨地区的无缝协作。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 在核子医学软体中整合人工智慧驱动的自动影像分析和临床决策支援平台
  • 云端基础的PACS 解决方案，支援核子医学部门之间的即时远端协作和数据共用
  • 先进的治疗诊断学工作流程管理系统，可优化个人化放射性核种治疗的计划和跟踪
  • 可互通的软体平台，用于无缝整合 PET/CT、SPECT 和多种模式的混合成像模式
  • 实施资料安全和符合 HIPAA 标准的加密通讯协定，以保护软体内的核医患者数据
  • 引入预测性维护和物联网设备监控模组，整合到核子医学资讯科学中
  • 采用标准化 DICOM SR 和 HL7 FHIR通讯协定可改善核医领域的跨供应商资料交换和报告自动化

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章：核医软体市场（依产品类型）

  • 核子医学分析软体
  • 核子医学临床决策支援软体
  • 核子医学资料管理软体
  • 核子医学影像软体
  • 核子医学放射治疗软体

9. 核子医学软体市场（依工作流程）

  • 资料管理
  • 资料处理
  • 影像撷取
  • 报告

第 10 章核医软体市场（按整合）

  • 融合的
  • 独立

第 11 章核医软体市场（按功能）

  • 诊断
  • 治疗

第 12 章。按部署模式分類的核子医学软体市场

  • 云端基础
  • 本地

第十三章核医软体市场（按应用）

  • 心臟病学
  • 感染疾病
  • 神经病学
  • 肿瘤学
    • 癌症分期和监测
    • 放射治疗计划和剂量测定
    • 治疗目标
    • 肿瘤检测与诊断
  • 整形外科
  • 小儿科

第 14 章核医软体市场（按最终用户）

  • 诊断影像中心
  • 医院
  • 研究所

15.美国核子医学软体市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

16.欧洲、中东和非洲核子医学软体市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

17.亚太核医学软体市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十八章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Bracco Group
    • Canon Medical Systems Corporation
    • Comecer SpA
    • Convergent Imaging Solutions
    • ec2 Software Solutions
    • Esaote SpA
    • Gamma Gurus Pty Ltd
    • GE Healthcare
    • Hermes Medical Solutions, Inc.
    • InMed Healthcare
    • Koninklijke Philips NV
    • LabLogic Systems Ltd.
    • Mediso Medical Imaging Systems
    • MIM Software Inc.
    • Mirada Medical Ltd. by Sectra AB
    • Mirion Technologies Inc.
    • Segami Corporation
    • Siemens Healthineers AG
    • Syntermed Inc.
    • Winkgen Medical Systems GmbH & Co. KG

第十九章 研究人工智慧

第20章 研究统计

第21章 研究联络人

第22章 研究报导

第23章 附录

Product Code: MRR-7D9A8454DC6E

The Nuclear Medicine Software Market was valued at USD 912.15 million in 2024 and is projected to grow to USD 997.53 million in 2025, with a CAGR of 9.52%, reaching USD 1,574.80 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 912.15 million
Estimated Year [2025] USD 997.53 million
Forecast Year [2030] USD 1,574.80 million
CAGR (%) 9.52%

Driving Innovation in Nuclear Medicine Software to Elevate Diagnostic Accuracy, Streamline Workflows, and Improve Patient Care Outcomes

The landscape of diagnostic imaging and therapeutic planning is undergoing a profound transformation driven by advances in nuclear medicine software. As healthcare providers strive for greater diagnostic precision and personalized treatment protocols, software solutions have evolved far beyond simple image visualization. Modern nuclear medicine platforms now integrate sophisticated algorithms and real-time analytics to enhance lesion detection, quantify radiotracer uptake, and support complex treatment planning workflows. By harnessing machine learning models, clinical teams can identify subtle patterns in multimodal data that were previously undetectable, ultimately driving better patient outcomes.

Concurrently, the shift toward cloud-native architectures and interoperable data standards has reshaped how institutions manage imaging studies and associated metadata. Rather than siloed on-premises installations, many organizations are adopting hybrid or fully cloud-based deployments, enabling distributed access, seamless collaboration, and centralized data governance. This evolution supports accelerated clinical trials, retrospective studies, and multi-site networks that collectively fuel innovation. With regulatory bodies placing greater emphasis on patient data security and traceability, vendors are embedding robust compliance frameworks into their offerings. These capabilities ensure that as clinical environments become more digitized, they remain aligned with stringent privacy and quality requirements.

Together, these technological and infrastructural shifts mark the beginning of a new era for nuclear medicine software-one in which diagnostic accuracy, workflow efficiency, and patient-centric approaches converge to redefine the standards of care.

Unveiling the Revolutionary Shifts Transforming Nuclear Medicine Software Architectures, Data Workflows, Analytics Capabilities, and Clinical Decision Support Paradigms

The nuclear medicine software ecosystem is experiencing a cascade of transformative developments that extend from core architectures to end-user applications. Artificial intelligence and deep learning techniques have moved from pilot studies into mainstream diagnostic modules, enabling automated lesion segmentation, anomaly detection, and predictive analytics. These tools are no longer standalone experiments; they are increasingly embedded within clinical decision support systems, augmenting physician expertise and reducing inter-operator variability.

Parallel to AI integration, the adoption of cloud and edge computing infrastructures has accelerated. This hybrid model allows for latency-sensitive tasks such as image acquisition and preliminary processing to occur locally, while more computationally intensive analytics and data archiving migrate to centralized cloud platforms. The result is a seamless patient journey from imaging suite to multidisciplinary review boards, complete with advanced visualization tools and collaborative annotations. Moreover, standardized integration frameworks such as DICOMweb and HL7 FHIR have improved interoperability, ensuring that systems from different vendors can share and interpret data consistently.

Regulatory frameworks are also evolving in response to these technological leaps. Agencies are updating guidelines to address the validation of AI algorithms and the secure handling of cloud-based health information. As a consequence, vendors and healthcare institutions are establishing formal governance committees and risk-management processes, ensuring that new solutions meet both clinical efficacy and compliance standards. Together, these shifts redefine what is possible within nuclear medicine software and set the stage for the next wave of innovation.

Assessing the Ripple Effects of Escalating United States Tariff Policies on Nuclear Medicine Software Supply Chains, Costs, and Innovation Pathways in 2025

Evolving tariff policies enacted by the United States in 2025 have introduced a complex dynamic into the supply chains that underpin nuclear medicine software development and deployment. Many specialized hardware components and cloud infrastructure services sourced internationally are now subject to increased import duties. As a direct result, software vendors face elevated operational expenses and must reassess global procurement strategies. Some providers have responded by diversifying manufacturing locations or investing in domestic assembly partnerships to mitigate cost escalations.

These adjustments have also influenced software licensing models. Vendors are exploring subscription-based pricing structures and tiered support packages to absorb the impact of higher hardware costs without transferring the full burden to end users. Such flexibility helps maintain adoption momentum, particularly among mid-sized hospitals and independent imaging centers that operate under tighter budgetary constraints. In parallel, capital investments in R&D continue to prioritize modular, scalable architectures that can adapt to shifting economic conditions, ensuring that new feature rollouts remain financially viable.

Looking ahead, collaboration between industry consortia and government agencies is emerging as a crucial mitigation strategy. By advocating for tariff exemptions on critical imaging components and promoting domestic innovation clusters, stakeholders aim to stabilize supply networks. This cooperative approach not only addresses immediate cost pressures but also fosters a resilient ecosystem capable of sustaining long-term advances in nuclear medicine software.

Revealing Critical Segmentation Insights Across Product Types, Workflows, Integrations, Functionalities, Deployment Models, Applications, and End User Needs in Nuclear Medicine Software

Segmentation analysis reveals nuanced opportunities across multiple dimensions of nuclear medicine software offerings and user requirements. Within product portfolios, imaging software commands significant attention for its intuitive user interfaces and advanced reconstruction algorithms, while clinical decision support modules leverage predictive analytics to guide therapy options. Data management platforms focus on secure storage, retrieval, and compliance tracking, and radiation therapy planning solutions integrate dosimetry calculations with patient-specific anatomical models. Each product category addresses distinct clinical challenges, shaping vendor roadmaps and investment priorities.

Workflow segmentation further highlights how data management capabilities underpin both image acquisition and processing operations. Systems that offer seamless orchestration from initial capture through reporting deliver measurable improvements in throughput and report turnaround times. Integration models differentiate between turnkey solutions that embed analytics within a unified platform and standalone applications that can be combined into bespoke workflows. In this context, organizations weigh the benefits of end-to-end interoperability against the agility of best-of-breed tools.

Functionality segmentation underscores the dual imperatives of diagnostics and therapeutics. Diagnostic modules prioritize sensitivity and specificity in detecting pathologies such as neurodegenerative disorders or cardiac perfusion defects. Meanwhile, therapeutic applications emphasize precision in radiation dose calculations and treatment planning for oncology cases, including staging, monitoring, and targeted interventions. Deployment choices span from on-premises installations favored by institutions with strict data residency policies to cloud-based services that support distributed care networks. Across all segments, end users-from diagnostic imaging centers to major hospital systems and research institutes-seek solutions that align with organizational goals and patient care mandates.

Exploring Diverse Regional Dynamics Shaping Nuclear Medicine Software Adoption Trends, Growth Drivers, Regulatory Environments, and Infrastructure Developments Globally

Regional analysis reveals distinct adoption patterns and strategic priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced healthcare infrastructure, coupled with supportive reimbursement policies for diagnostic imaging and targeted therapies, drives substantial uptake of cloud-native and AI-enabled platforms. Leading institutions invest heavily in software that integrates seamlessly with existing PACS networks and electronic health records, prioritizing solutions that enhance operational efficiency and patient throughput.

Across Europe, Middle East & Africa, diverse regulatory environments and funding structures shape vendor strategies. The European Union's harmonized medical device regulations encourage standardization and interoperability, while individual countries balance innovation incentives with strict data privacy requirements. In the Middle East, government-funded health initiatives accelerate software deployments in cutting-edge centers of excellence. Meanwhile, Africa's emerging markets present both infrastructure challenges and high-impact opportunities, prompting flexible deployment models tailored to local connectivity and resource constraints.

In Asia-Pacific, rapid modernization of healthcare systems and growing investments in cancer diagnostics spur demand for integrated imaging and therapy planning solutions. Governments in key markets actively support digital health transformations through public-private partnerships, enabling providers to pilot advanced analytics and remote collaboration capabilities. Cost-sensitivity remains an important factor, encouraging vendors to offer scalable licensing options that align with diverse institutional budgets.

Profiling Leading Innovators and Emerging Players in Nuclear Medicine Software Market Highlighting Strategic Partnerships, Technological Breakthroughs, and Competitive Positioning

Leading technology providers continue to refine core platforms through strategic partnerships, acquisitions, and in-house innovation. Major incumbents are expanding their portfolios to include advanced analytics modules, leveraging proprietary machine learning frameworks that accelerate lesion quantification and treatment response assessments. Simultaneously, agile startups are carving out niche positions by focusing on specialized clinical applications such as pediatric imaging or infectious disease monitoring, forging collaborations with academic medical centers to validate their algorithms under real-world conditions.

Competitive differentiation increasingly hinges on interoperability and ecosystem integration. Vendors that offer open APIs and adhere to emerging data standards gain an edge by enabling seamless connectivity with a range of imaging modalities and electronic health record systems. Moreover, alliances between software developers and major imaging hardware manufacturers are driving co-developed solutions that embed analytics directly into imaging consoles, reducing manual data transfers and enhancing workflow continuity.

Investment activity underscores the sector's vitality. Recent funding rounds and joint development agreements have bolstered efforts to deploy cloud-native infrastructures capable of real-time collaboration across global research networks. As competition intensifies, providers are prioritizing customer success programs and professional services, ensuring that end users can rapidly adopt new features, optimize performance, and maintain compliance within evolving regulatory frameworks.

Delivering Actionable Recommendations for Industry Leaders to Capitalize on Technological Advances, Optimize Investments, and Strengthen Strategic Positioning in Nuclear Medicine Software

Industry leaders should prioritize the adoption of AI-driven analytics to enhance accuracy and operational efficiency. By integrating validated models into existing workflows, organizations can reduce interpretation times and support earlier clinical interventions. At the same time, embracing cloud-native architectures with modular components ensures scalability and flexibility, enabling rapid deployment across both centralized hospitals and decentralized outpatient imaging centers.

To maintain resilience in the face of supply chain disruptions and tariff fluctuations, companies are advised to diversify sourcing strategies and cultivate strategic partnerships with domestic manufacturers. This approach mitigates cost volatility and sustains development timelines for critical software upgrades. In parallel, establishing open standards for interoperability will accelerate multi-vendor integration, allowing institutions to select best-of-breed solutions that align with their clinical and operational requirements.

Furthermore, aligning product roadmaps with emerging therapeutic trends-such as precision oncology and theranostics-can unlock new revenue streams and differentiate offerings. Investing in robust cybersecurity frameworks and comprehensive training programs will foster stakeholder confidence, ensuring that regulatory compliance and patient data protection remain top priorities. By combining these strategies, industry leaders can position themselves to capitalize on the next wave of innovation in nuclear medicine software.

Outlining Rigorous Research Methodology Leveraging Primary Interviews, Secondary Data Validation, and Robust Analytical Techniques to Ensure Insights Accuracy and Reliability

The research team adopted a multi-phase methodology designed to ensure comprehensive and reliable insights. Initial scoping involved extensive desk research, leveraging peer-reviewed journals, regulatory publications, and domain-specific white papers to define market boundaries and identify key stakeholders. This phase provided the foundation for targeted primary research activities, which comprised structured interviews with clinical leaders, software developers, radiology department heads, and compliance experts.

Quantitative data gathered through professional surveys and anonymized usage statistics was subjected to rigorous validation processes. Findings were cross-referenced with public filings, conference proceedings, and case studies to confirm consistency. Qualitative insights were synthesized through thematic analysis, enabling the team to contextualize numerical trends within the perspectives of frontline practitioners.

Subsequently, advanced analytical techniques were applied to uncover hidden correlations between technology adoption patterns, clinical outcomes, and regulatory trajectories. Scenario planning workshops with in-house subject-matter experts tested the robustness of assumptions under varied economic and policy conditions. Finally, a multi-tiered peer review and editorial process ensured that the report's conclusions are both defensible and actionable for decision-makers.

Synthesizing Key Findings on Technological Trends, Market Drivers, Regional Variations, and Strategic Imperatives Guiding the Future of Nuclear Medicine Software Ecosystem

Through this study, it becomes evident that nuclear medicine software is entering a pivotal phase defined by the convergence of artificial intelligence, cloud computing, and precision therapeutics. Technological breakthroughs in machine learning algorithms are enhancing diagnostic accuracy and empowering clinicians to make faster, more informed decisions. At the same time, the shift toward interoperable, cloud-native solutions is reshaping data workflows, enabling seamless collaboration across institutions and geographies.

Regional dynamics further illustrate how adoption strategies vary according to healthcare infrastructure maturity, regulatory frameworks, and economic considerations. Companies that tailor their offerings to these local nuances are well positioned to capture new opportunities. The cumulative effects of evolving tariff policies underscore the importance of resilient supply chains and adaptive pricing models. Key market players continue to differentiate through strategic partnerships, open standards integration, and focused R&D investments in high-impact applications such as oncology and neurology.

By following the actionable recommendations outlined in this report and leveraging the detailed segmentation and regional analyses, stakeholders can navigate the complexities of the nuclear medicine software ecosystem. Ultimately, organizations that align technological innovation with operational excellence and regulatory compliance will lead the transformation toward more precise, personalized patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of AI-driven automated image analysis with clinical decision support platforms in nuclear medicine software
  • 5.2. Cloud-based PACS solutions enabling real-time remote collaboration and data sharing among nuclear medicine departments
  • 5.3. Advanced theranostics workflow management systems optimizing personalized radionuclide therapy planning and tracking
  • 5.4. Interoperable software platforms for seamless integration of PET/CT, SPECT, and hybrid imaging modalities across modalities
  • 5.5. Implementation of data security and HIPAA-compliant encryption protocols to safeguard nuclear medicine patient data in software
  • 5.6. Deployment of predictive maintenance and IoT-enabled equipment monitoring modules integrated into nuclear medicine informatics
  • 5.7. Adoption of standardized DICOM SR and HL7 FHIR protocols for improved cross-vendor data exchange and reporting automation in nuclear medicine

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Nuclear Medicine Software Market, by Product Type

  • 8.1. Introduction
  • 8.2. Nuclear Medicine Analysis Software
  • 8.3. Nuclear Medicine Clinical Decision Support Software
  • 8.4. Nuclear Medicine Data Management Software
  • 8.5. Nuclear Medicine Imaging Software
  • 8.6. Nuclear Medicine Radiation Therapy Software

9. Nuclear Medicine Software Market, by Workflow

  • 9.1. Introduction
  • 9.2. Data Management
  • 9.3. Data Processing
  • 9.4. Image Acquisition
  • 9.5. Reporting

10. Nuclear Medicine Software Market, by Integration

  • 10.1. Introduction
  • 10.2. Integrated
  • 10.3. Standalone

11. Nuclear Medicine Software Market, by Functionality

  • 11.1. Introduction
  • 11.2. Diagnostics
  • 11.3. Therapeutics

12. Nuclear Medicine Software Market, by Deployment Mode

  • 12.1. Introduction
  • 12.2. Cloud Based
  • 12.3. On Premises

13. Nuclear Medicine Software Market, by Application

  • 13.1. Introduction
  • 13.2. Cardiology
  • 13.3. Infectious Diseases
  • 13.4. Neurology
  • 13.5. Oncology
    • 13.5.1. Cancer Staging & Monitoring
    • 13.5.2. Radiation Therapy Planning & Dosimetry
    • 13.5.3. Therapeutic Targeting
    • 13.5.4. Tumor Detection and Diagnosis
  • 13.6. Orthopedics
  • 13.7. Pediatrics

14. Nuclear Medicine Software Market, by End User

  • 14.1. Introduction
  • 14.2. Diagnostic Imaging Centers
  • 14.3. Hospitals
  • 14.4. Research Institutes

15. Americas Nuclear Medicine Software Market

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. Argentina

16. Europe, Middle East & Africa Nuclear Medicine Software Market

  • 16.1. Introduction
  • 16.2. United Kingdom
  • 16.3. Germany
  • 16.4. France
  • 16.5. Russia
  • 16.6. Italy
  • 16.7. Spain
  • 16.8. United Arab Emirates
  • 16.9. Saudi Arabia
  • 16.10. South Africa
  • 16.11. Denmark
  • 16.12. Netherlands
  • 16.13. Qatar
  • 16.14. Finland
  • 16.15. Sweden
  • 16.16. Nigeria
  • 16.17. Egypt
  • 16.18. Turkey
  • 16.19. Israel
  • 16.20. Norway
  • 16.21. Poland
  • 16.22. Switzerland

17. Asia-Pacific Nuclear Medicine Software Market

  • 17.1. Introduction
  • 17.2. China
  • 17.3. India
  • 17.4. Japan
  • 17.5. Australia
  • 17.6. South Korea
  • 17.7. Indonesia
  • 17.8. Thailand
  • 17.9. Philippines
  • 17.10. Malaysia
  • 17.11. Singapore
  • 17.12. Vietnam
  • 17.13. Taiwan

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Bracco Group
    • 18.3.2. Canon Medical Systems Corporation
    • 18.3.3. Comecer S.p.A.
    • 18.3.4. Convergent Imaging Solutions
    • 18.3.5. ec2 Software Solutions
    • 18.3.6. Esaote S.p.A.
    • 18.3.7. Gamma Gurus Pty Ltd
    • 18.3.8. GE Healthcare
    • 18.3.9. Hermes Medical Solutions, Inc.
    • 18.3.10. InMed Healthcare
    • 18.3.11. Koninklijke Philips N.V
    • 18.3.12. LabLogic Systems Ltd.
    • 18.3.13. Mediso Medical Imaging Systems
    • 18.3.14. MIM Software Inc.
    • 18.3.15. Mirada Medical Ltd. by Sectra AB
    • 18.3.16. Mirion Technologies Inc.
    • 18.3.17. Segami Corporation
    • 18.3.18. Siemens Healthineers AG
    • 18.3.19. Syntermed Inc.
    • 18.3.20. Winkgen Medical Systems GmbH & Co. KG

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

  • FIGURE 1. NUCLEAR MEDICINE SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 18. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 22. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. ASIA-PACIFIC NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 26. ASIA-PACIFIC NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 27. NUCLEAR MEDICINE SOFTWARE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. NUCLEAR MEDICINE SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 29. NUCLEAR MEDICINE SOFTWARE MARKET: RESEARCHAI
  • FIGURE 30. NUCLEAR MEDICINE SOFTWARE MARKET: RESEARCHSTATISTICS
  • FIGURE 31. NUCLEAR MEDICINE SOFTWARE MARKET: RESEARCHCONTACTS
  • FIGURE 32. NUCLEAR MEDICINE SOFTWARE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. NUCLEAR MEDICINE SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE ANALYSIS SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE CLINICAL DECISION SUPPORT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE CLINICAL DECISION SUPPORT SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE IMAGING SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE IMAGING SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE RADIATION THERAPY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NUCLEAR MEDICINE RADIATION THERAPY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DATA PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DATA PROCESSING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY IMAGE ACQUISITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY IMAGE ACQUISITION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY REPORTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY REPORTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY STANDALONE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY CLOUD BASED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ON PREMISES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ON PREMISES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY CANCER STAGING & MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY CANCER STAGING & MONITORING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY RADIATION THERAPY PLANNING & DOSIMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY RADIATION THERAPY PLANNING & DOSIMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY THERAPEUTIC TARGETING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY THERAPEUTIC TARGETING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY TUMOR DETECTION AND DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY TUMOR DETECTION AND DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 83. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 101. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 102. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 103. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 104. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 117. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 119. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 120. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 121. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 122. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 123. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 124. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 127. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 128. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 133. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 135. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 136. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 137. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 138. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 139. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 140. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 141. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 142. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 143. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 145. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 149. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 151. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 152. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 153. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 154. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 155. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 156. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 157. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 158. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 159. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 161. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 163. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. BRAZIL NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 165. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 168. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 169. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 170. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 171. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 172. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 173. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 174. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 175. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 177. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 179. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. ARGENTINA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED KINGDOM NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 215. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 218. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 219. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 220. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 221. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 222. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 223. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 224. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 225. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 227. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 229. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. GERMANY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 231. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 233. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 234. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 235. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 236. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 237. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 238. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 239. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 240. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 241. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 243. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 245. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. FRANCE NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 247. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 250. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 251. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 252. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 253. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 254. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 255. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 256. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 257. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 259. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 261. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. RUSSIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 263. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 266. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 267. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 268. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 269. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 270. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 271. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 272. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 273. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 275. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 277. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. ITALY NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 281. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 282. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 283. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 284. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 285. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 286. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 287. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 288. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 289. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 293. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. SPAIN NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 295. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 297. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 299. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 301. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 303. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
  • TABLE 305. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 307. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 314. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY WORKFLOW, 2025-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2018-2024 (USD MILLION)
  • TABLE 316. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY INTEGRATION, 2025-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
  • TABLE 318. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA NUCLEAR MEDICINE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
  • TABLE 320. SAUDI AR